REAGENTS TEST KITS
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAVAL MEDICAL RESEARCH CENTER
Contract Value
Not provided
Codes & Classification
Solicitation Number
N3239826Q4854
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
6640
Additional Details
The United States Department of the Navy, through its Naval Medical Research Center (NMRC), has issued a Special Notice regarding its intent to procure a range of Illumina brand reagents and test kits. This procurement is intended to support the NMRC’s ongoing research and development activities in biotechnology, specifically in the area of respiratory virus and pathogen detection and analysis. The acquisition will be conducted under the guidelines of FAR Part 12 for Commercial Items, and is classified under NAICS code 541714, which covers Research and Development in Biotechnology (except Nanobiotechnology). The Product Service Code associated with this requirement is 6640.
The scope of this procurement encompasses a comprehensive suite of Illumina reagents and enrichment kits, including but not limited to: Respiratory Virus Enrichment Kit Sets (A-D), Respiratory Virus Oligos Panel V2, PhiX Control v3, NextSeq and MiSeq reagent kits, Respiratory Pathogen ID/AMR Enrichment Kits, and DNA/RNA UD Indexes Sets for tagmentation. These products are essential for high-throughput sequencing and molecular analysis, supporting NMRC’s mission to advance medical research and enhance the Department of Defense’s capabilities in infectious disease surveillance and response.
This notice specifies that the requirement is for authorized, approved vendors to provide services and supplies for brand name Illumina equipment. The NMRC intends to award the contract to Illumina Inc., located in San Diego, CA, on a basis other than full and open competition. However, the government will consider capability statements from interested parties who believe they can meet the requirements with authorized Illumina products. It is important to note that this is not a request for competitive proposals.
Key requirements for interested contractors include registration in the System for Award Management (SAM) and possession of a Unique Entity Identification Number (UEI). No award will be made to any vendor not registered in SAM. Detailed instructions for registration are provided in the notice.
The place of performance for this contract is within the United States. The contracting activity is managed by the Naval Medical Research Center, a federal office under the Department of Defense and the Department of the Navy. The primary point of contact for this procurement is Nataki Johnson ([email protected]), with Shamai Carter ([email protected]) listed as the secondary contact.
This opportunity is currently active, with a response deadline of June 30, 2026. Contractors with the capability to supply authorized Illumina reagents and test kits in accordance with the specified requirements are encouraged to submit their statements of capability by the stated deadline.
For further details and to access the official notice, interested parties should refer to the SAM.gov opportunity at: https://sam.gov/opp/ba4009950d654655be8ac2463bfab458/view.